RegenMedTX Overview
- Founded
- 2014
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
RegenMedTX General Information
Description
Developer of cell therapies for chronic kidney disease. The company develops cell therapy products that are programmed in the body to restore damaged kidney tissues by engrafting into, repairing or replacing damaged tissues or organ.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 3929 Westpoint Boulevard
- Suite G
- Winston-Salem, NC 27103
- United States
+1 (336) 000-0000
RegenMedTX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 01-Mar-2016 | 00.000 | Completed | Startup | ||
| 1. Angel (individual) | 05-Aug-2015 | 00.000 | 00.000 | Completed | Startup |
RegenMedTX Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Timothy Bertram Ph.D | Chief Executive Officer, Board Member and Managing Director | ||
| Deepak Jain Ph.D | Chief Operating Officer |
RegenMedTX Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Kim Westmoreland | Self | Board Member | 000 0000 |
| Timothy Bertram Ph.D | RegenMedTX | Chief Executive Officer, Board Member and Managing Director | 000 0000 |
| William Hawkins III | Self | Chairman | 000 0000 |
RegenMedTX Investments & Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 | 06-Mar-2015 | 000000000000000000 | 000.00 | Biotechnology | |
| Tengion | Secondary Transaction - Private | Biotechnology |